Carl Zeiss Meditec AG (AFXG)

79.34 +0.04 (+0.05%)
Closed EUR Disclaimer

AFXG Dividends

Ex-Dividend Date
Dividend
EPS Payout Ratio
Type
Payment Date
Yield
Mar 23, 2023 1.1 193% Annual Mar 27, 2023 0.83%
Mar 31, 2022 0.9 214% Annual Apr 04, 2022 0.60%
May 28, 2021 0.5 82% Annual Jun 01, 2021 0.33%
Aug 07, 2020 0.65 232% Annual Aug 11, 2020 0.71%
Mar 20, 2019 0.55 172% Annual Mar 22, 2019 0.69%
Apr 11, 2018 0.55 172% Annual Apr 13, 2018 1.05%
May 31, 2017 0.42 55% Annual Jun 02, 2017 0.91%
Apr 07, 2016 0.38 Annual Apr 07, 2016 1.31%
Mar 19, 2015 0.4 Other Dividend Mar 19, 2015 1.61%
Mar 05, 2014 0.45 Annual Mar 05, 2014 2.11%
Mar 06, 2013 0.4 Annual Mar 06, 2013 1.65%
Mar 12, 2012 0.3 Annual Mar 12, 2012 1.74%
Apr 13, 2011 0.22 Annual Apr 13, 2011 1.47%
Apr 13, 2011 0.33 Bonus Payment Apr 13, 2011 3.67%
Mar 05, 2010 0.18 Annual Mar 05, 2010 1.59%
May 20, 2009 0.18 Annual May 20, 2009 1.93%
Mar 10, 2008 0.27 Bonus Payment Mar 10, 2008 4.56%
Mar 10, 2008 0.16 Annual Mar 10, 2008 1.69%
Mar 12, 2007 0.14 Annual Mar 12, 2007 0.80%
Mar 13, 2006 0.16 Annual Apr 13, 2006 0.57%
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.